Full name
PRZEDSIĘBIORSTWO FARMACEUTYCZNE "ZIOŁOLEK" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOSCIĄ
uses securityreCAPTCHA
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10 - Manufacture of food products
20 - Manufacture of chemicals and chemical products
20.42 - Manufacture of cosmetics and toilet preparations
32.50 - Production of medical devices, instruments, and products, including dental products
46 - Wholesale trade
46.45 - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75 - Wholesale trade
72 - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 4,4 | 0,2 | 0,4 | 45,4 |
EBITDA | 5,2 | 1,2 | 2,4 | 93,4 |
Short time liabilities | 4,8 | 9,1 | 9,9 | 8,1 |
Equity capital | 29,5 | 28,5 | 28,7 | 0,6 |
Operating profit (EBIT) | 4,6 | 0,6 | 1,3 | 106,5 |
Assets | 34,7 | 39,5 | 43,5 | 10,2 |
Net profit (loss) | 3,7 | 0,2 | 0,2 | 50,9 |
Cash | 2,8 | 0,2 | 0,2 | 25,7 |
Net income from sale | 38,5 | 38,7 | 41,1 | 6 |
Liabilities and provisions for liabilities | 5,3 | 10,9 | 14,8 | 35,2 |
Working assets | 15,9 | 16,3 | 17,2 | 5,6 |
Depreciation | 0,6 | 0,6 | 1,1 | 80,3 |
% | % | % | p.p. | |
Profitability of capital | 12,4 | 0,5 | 0,8 | 0,3 |
Equity capital to total assets | 84,9 | 72,3 | 66,1 | -6,2 |
Gross profit margin | 11,5 | 0,6 | 0,9 | 0,3 |
EBITDA Margin | 13,6 | 3,2 | 5,8 | 2,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 46 | 86 | 88 | 2 |
Current financial liquidity indicator | 3.3109347820281982 | 1.7871065139770508 | 1.737676978111267 | -0,1 |
Net dept to EBITDA | -0.39902061223983765 | 4.46218729019165 | 3.102808952331543 | -1,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane